Emcure Pharma Live Share Price Today, Share Analysis and Chart

Name: Emcure Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Emcure Pharmaceuticals Ltd.
Rating: 3.050958375
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

In 2 Starfolio Baskets

Iran war impact

Based on the analysis of Emcure Pharmaceuticals Ltd. (EMCURE) financial disclosures and operational updates for FY2025 and 9M FY2026, the impact of the ongoing conflict in the Middle East is as follows: ##### Impact Assessment: Minimal to Moderate Ne...

1634.20 -12.60 (-0.77%)

Near 52W High of ₹1671.80

89,134

NSE+BSE Volume

NSE 16 Apr, 2026 11:48 AM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Moderately Bullish

66.9 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

1,796

1Yr Price target upside is 10%

6 analysts

Emcure Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Emcure Pharma Live Share Price Today, Share Analysis and Chart

Based on the analysis of Emcure Pharmaceuticals Ltd. (EMCURE) financial disclosures and operational updates for FY2025 and 9M FY2026, the impact of the ongoing conflict in the Middle East is as follows: ##### Impact Assessment: Minimal to Moderate Ne...

Near 52W High of ₹1671.80

SWOT Analysis

Emcure Pharma Live Price Chart